Resources
Anemia happens when you do not have enough red blood cells. The cells travel with iron and hemoglobin, which is a protein that helps carry oxygen through the bloodstream to your organs all through the body.
5/5
Anemia treatment depends on the cause. Treatment for iron deficiency anemia usually involves taking iron supplements and changing your diet. Treatment for folic acid and vitamin C deficiency involves dietary supplements and increasing these nutrients in your diet. Treatment for aplastic anemia can include blood transfusions to boost levels of red blood cells. Treatment for sickle cell anemia might include oxygen, pain relievers, and oral and intravenous fluids to reduce pain and prevent complications. Most forms of thalassemia are mild and require no treatment.
The table below includes the most commonly used ICD-10 Codes for anemia:
ICD-10 Chapter | Codes | Code Description |
---|---|---|
3 | D50.0 | Iron deficiency anemia secondary to blood loss (chronic) |
3 | D50.1 | Sideropenic dysphagia |
3 | D50.8 | Other iron deficiency anemias |
3 | D50.9 | Iron deficiency anemia, unspecified |
3 | D51.0 | Vitamin B12 deficiency anemia due to intrinsic factor deficiency |
3 | D51.1 | Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with proteinuria |
3 | D51.2 | Transcobalamin II deficiency |
3 | D51.3 | Other dietary vitamin B12 deficiency anemia |
3 | D51.8 | Other vitamin B12 deficiency anemias |
3 | D51.9 | Vitamin B12 deficiency anemia, unspecified |
3 | D52.0 | Dietary folate deficiency anemia |
3 | D52.1 | Drug-induced folate deficiency anemia |
3 | D52.8 | Other folate deficiency anemias |
3 | D52.9 | Folate deficiency anemia, unspecified |
3 | D53.0 | Protein deficiency anemia |
3 | D53.1 | Other megaloblastic anemias, not elsewhere classified |
3 | D53.2 | Scorbutic anemia |
3 | D53.8 | Other specified nutritional anemias |
3 | D53.9 | Nutritional anemia, unspecified |
3 | D55.0 | Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency |
3 | D55.1 | Anemia due to other disorders of glutathione metabolism |
3 | D55.2 | Anemia due to disorders of glycolytic enzymes |
3 | D55.3 | Anemia due to disorders of nucleotide metabolism |
3 | D55.8 | Other anemias due to enzyme disorders |
3 | D55.9 | Anemia due to enzyme disorder, unspecified |
3 | D56.0 | Alpha thalassemia |
3 | D56.1 | Beta thalassemia |
3 | D56.2 | Delta-beta thalassemia |
3 | D56.3 | Thalassemia minor |
3 | D56.4 | Hereditary persistence of fetal hemoglobin [HPFH] |
3 | D56.5 | Hemoglobin E-beta thalassemia |
3 | D56.8 | Other thalassemias |
3 | D56.9 | Thalassemia, unspecified |
3 | D57.00 | Hb-SS disease with crisis unspecified |
3 | D57.01 | Hb-SS disease with acute chest syndrome |
3 | D57.02 | Hb-SS disease with splenic sequestration |
3 | D57.1 | Sickle-cell disease without crisis |
3 | D57.20 | Sickle-cell/Hb-C disease without crisis |
3 | D57.211 | Sickle-cell/Hb-C disease with acute chest syndrome |
3 | D57.212 | Sickle-cell/Hb-C disease with splenic sequestration |
3 | D57.219 | Sickle-cell/Hb-C disease with crisis, unspecified |
3 | D57.3 | Sickle-cell trait |
3 | D57.40 | Sickle-cell thalassemia, without crisis |
3 | D57.411 | Sickle-cell thalassemia with acute chest syndrome |
3 | D57.412 | Sickle-cell thalassemia with splenic sequestration |
3 | D57.419 | Sickle-cell thalassemia with crisis unspecified |
3 | D57.80 | Other sickle-cell disorders, without crisis |
3 | D57.811 | Other sickle-cell disorders with acute chest syndrome |
3 | D57.812 | Other sickle-cell disorders with splenic sequestration |
3 | D57.819 | Other sickle-cell disorders with crisis, unspecified |
3 | D58.0 | Hereditary spherocytosis |
3 | D58.1 | Hereditary elliptocytosis |
3 | D58.2 | Other hemoglobinopathies |
3 | D58.8 | Other specified hereditary hemolytic anemias |
3 | D58.9 | Hereditary hemolytic anemia, unspecified |
3 | D59.0 | Drug-induced autoimmune hemolytic anemia |
3 | D59.1 | Other autoimmune hemolytic anemias |
3 | D59.2 | Drug-induced nonautoimmune hemolytic anemia |
3 | D59.3 | Hemolytic-uremic syndrome |
3 | D59.4 | Other nonautoimmune hemolytic anemias |
3 | D59.5 | Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli] |
3 | D59.6 | Hemoglobinuria due to hemolysis from other external causes |
3 | D59.8 | Other acquired hemolytic anemias |
3 | D59.9 | Acquired hemolytic anemia, unspecified |
3 | D60.0 | Chronic acquired pure red cell aplasia |
3 | D60.1 | Transient acquired pure red cell aplasia |
3 | D60.8 | Other acquired pure red cell aplasias |
3 | D60.9 | Acquired pure red cell aplasia, unspecified |
3 | D61.01 | Constitutional (pure) red blood cell aplasia |
3 | D61.09 | Other constitutional aplastic anemia |
3 | D61.1 | Drug-induced aplastic anemia |
3 | D61.2 | Aplastic anemia due to other external agents |
3 | D61.3 | Idiopathic aplastic anemia |
3 | D61.810 | Antineoplastic chemotherapy induced pancytopenia |
3 | D61.811 | Other drug-induced pancytopenia |
3 | D61.818 | Other pancytopenia |
3 | D61.82 | Myelophthisis |
3 | D61.89 | Other specified aplastic anemias and other bone marrow failure syndromes |
3 | D61.9 | Aplastic anemia, unspecified |
3 | D62 | Acute posthemorrhagic anemia |
3 | D63.0 | Anemia in neoplastic disease |
3 | D63.1 | Anemia in chronic kidney disease |
3 | D63.8 | Anemia in other chronic diseases classified elsewhere |
3 | D64.0 | Hereditary sideroblastic anemia |
3 | D64.1 | Secondary sideroblastic anemia due to disease |
3 | D64.2 | Secondary sideroblastic anemia due to drugs and toxins |
3 | D64.3 | Other sideroblastic anemias |
3 | D64.4 | Congenital dyserythropoietic anemia |
3 | D64.81 | Anemia due to antineoplastic chemotherapy |
3 | D64.89 | Other specified anemias |
3 | D64.9 | Anemia, unspecified |
Author: Tonoya Ahmed
DocCharge: Be productive again! Practice analytics, mobile charge capture, HIPAA compliant messaging, and tools for billers.
DocCharge is a mobile physician productivity platform enabling physicians and clinicians to save time by efficiently capture patient billings, communicate with back office and maximize revenue by avoiding lost charges using real-time analytics on a mobile device. Designed by a physician for fellow physicians, residents/fellows, and mid-level providers, DocCharge maximizes one’s productivity. Practice Administrators and outsourced billing companies find the application very intuitive, thus improving practice efficiency and revenue.
DocCharge is transforming healthcare data into useful and actionable insights, thereby allowing partner subscribers to focus their resources on the core business of providing high quality patient care. For more information, visit www.DocCharge.com, email: contact@DocCharge.com.